Rang	Name	Position
1	Mr. Thomas W. Eastling M.D.	Chief Financial Officer
2	Mr. Weiguo Ye	Chief Operating Officer
3	Ms. Ruoyu Chen	Chief Information Officer
4	Dr. Ying Luo Ph.D.	CEO, President & Director
5	Dr. Yue Xiong Ph.D.	Chief Scientific Officer & Director
6	Mr. Joshua Bergmann J.D.	General Counsel & Corporate Secretary
7	Seth Goldblum M.B.A.	Senior Vice President of Corporate Development
8	Mr. Jialiang Wang Ph.D.	Executive VP & GM
9	Jing Liu Ph.D.	Senior Vice President of Platform Chemistry
10	Mark Marino	Senior Vice President of Clinical Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HSG Holding Ltd	3,54%	26,59 Mio. USD
2	BlackRock Inc	0,94%	7,05 Mio. USD
3	Octagon Capital Advisors LP	0,90%	6,77 Mio. USD
4	Vanguard Capital Management, LLC	0,83%	6,22 Mio. USD
5	Geode Capital Management, LLC	0,50%	3,78 Mio. USD
6	State Street Corp	0,23%	1,74 Mio. USD
7	Charles Schwab Investment Management Inc	0,17%	1,31 Mio. USD
8	Northern Trust Corp	0,16%	1,20 Mio. USD
9	SBI Securities Co Ltd	0,16%	1,18 Mio. USD
10	Vanguard Fiduciary Trust Co	0,14%	1,07 Mio. USD
11	Vanguard Portfolio Management, LLC	0,12%	0,88 Mio. USD
12	The Goldman Sachs Group Inc	0,08%	0,61 Mio. USD
13	Bank of New York Mellon Corp	0,06%	0,45 Mio. USD
14	Morgan Stanley - Brokerage Accounts	0,04%	0,30 Mio. USD
15	STRS OHIO	0,02%	0,18 Mio. USD
16	Dimensional Fund Advisors, Inc.	0,02%	0,18 Mio. USD
17	AllianceBernstein L.P.	0,02%	0,17 Mio. USD
18	Nuveen, LLC	0,02%	0,17 Mio. USD
19	UBS Group AG	0,02%	0,13 Mio. USD
20	Millennium Management LLC	0,02%	0,13 Mio. USD